Hepregen Corporation (Ascendance Biotechnology)

Hepregen Corporation is developing bioengineered solutions for drug development, including a platform for advanced toxicity screening and drug discovery. With its high fidelity model of the human liver, Hepregen's bioengineered solution may provide improved predictivity of how drugs will affect the liver once in humans.

For the story of the Deshpande Center project that became Hepregen Corporation, see Case Studies.

This company is a spinout of the 2006 project, Human liver models for faster, safer drug development.